Long-Term Results of Combined Aortoiliac and Infrainguinal Arterial Reconstruction for the Treatment of Critical Limb Ischemia

Miyahara, Takuya; Shigematsu, Kunihiro; Nishiyama, Ayako; Hashimoto, Takeji; Hoshina, Katsuyuki; Watanabe, Toshiaki

doi:10.3400/avd.oa.14-00119

Cited by 5 publications

(2 citation statements)

References 26 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This could be ex- plained by a high secondary intervention rate (39 %) after anastomotic stenosis or bypass occlusion. The same conclusion can be made concerning the assisted and secondary patency at one year (66 %, 81 %) where the results in similar series are slightly higher (primary assisted patency: 93 % − 98 %; secondary patency: 91 % − 98 %) [19,21,22,24]. The fi nal objective of the hybrid approach is to take advantage of each technique related to the optimal patency rate, avoiding associated complications.…”

Section: Discussionsupporting

confidence: 61%

Surgical and endovascular hybrid approach in peripheral arterial disease of the lower limbs

Grandjean

Iglesias

Dubuis

et al. 2016

Vasa

View full text Add to dashboard Cite

We treated all of the patients in an operating theatre equipped with a dedicated portable C arm with a specifi c capacity for road mapping and image analysis (BV Pulsera, Philips, DA Best, and the Netherlands) associated with a radiolucent imaging Summary: Background: Multilevel peripheral arterial disease is frequently observed in patients with intermittent claudication or critical limb ischemia. This report evaluates the effi cacy of one-stage hybrid revascularization in patients with multilevel arterial peripheral disease. Patients and methods: A retrospective analysis of a prospective database included all consecutive patients treated by a hybrid approach for a multilevel arterial peripheral disease. The primary outcome was the patency rate at 6 months and 1 year. Secondary outcomes were early and midterm complication rate, limb salvage and mortality rate. Statistical analysis, including a Kaplan-Meier estimate and univariate and multivariate Cox regression analyses were carried out with the primary, primary assisted and secondary patency, comparing the impact of various risk factors in pre-and post-operative treatments. Results: 64 patients were included in the study, with a mean follow-up time of 428 days (range: 4 − 1140). The technical success rate was 100 %. The primary, primary assisted and secondary patency rates at 1 year were 39 %, 66 % and 81 %, respectively. The limb-salvage rate was 94 %. The early mortality rate was 3.1 %. Early and midterm complication rates were 15.4 % and 6.4 %, respectively. The early mortality rate was 3.1 %. Conclusions: The hybrid approach is a major alternative in the treatment of peripheral arterial disease in multilevel disease and comorbid patients, with low complication and mortality rates and a high limb-salvage rate.

show abstract

Section: Discussionsupporting

confidence: 61%

Surgical and endovascular hybrid approach in peripheral arterial disease of the lower limbs

Grandjean

Iglesias

Dubuis

et al. 2016

Vasa

View full text Add to dashboard Cite

show abstract

“…Multilevel complex lesions involving CFA in PAD patients are increasingly treated using hybrid procedures combining surgical endarterectomy and EVT [9,10]. During these procedures, FEA with patch angioplasty provides convenient access for simultaneous EVT of inflow and outflow lesions.…”

Section: Discussionmentioning

confidence: 99%

Long-Term Outcomes following Common Femoral Endarterectomy

Hashimoto

Yamamoto

Kimura

et al. 2022

JCM

Self Cite

View full text Add to dashboard Cite

Thromboendarterectomy of the common femoral artery (CFA) for occlusive disease is a crucial procedure in vascular surgery. As an outcome reference for emerging endovascular procedures and new devices, we need more robust evidence of the outcome of this gold standard technique. The purpose of this study was to report 10-year results after femoral endarterectomy (FEA). A retrospective review of medical records at our institution identified eighty consecutive patients (91 limbs) who underwent FEA for CFA lesions. Indications for FEA included 50 limbs (55%) for intermittent claudication (IC) and 39 limbs (43%) with chronic limb-threatening ischemia (CLTI). Two limbs (2%) underwent FEA to prevent hemodynamic steal during extra-anatomical bypass. Adjunctive procedures included endovascular therapy in 32%. CFAs were closed with patch angioplasty in 44%. With a mean follow-up period of 39 months, the survival rates at 3 and 8 years were 85% and 77%, respectively. Limb salvage rates were 92% and 87%. Primary patencies were 98% and 84%. Freedom from target lesion revascularization was 95% at 3 years and 91% at 8 years. Our findings support the durability of FEA, with comparable long-term procedural results in CLTI patients as well as IC patients. Since the FEA is a gate maneuver for hybrid revascularization in CLTI patients, our findings support a strategy combining open and endovascular approaches. Femoral endarterectomy remains a durable solution for common femoral occlusive disease in IC and CLTI in the era of endovascular therapy.

show abstract

Comparative evaluation of long-term outcomes of various open surgeries on the aortofemoral segment in patients with critical lower limb ischemia

Rakhmatillaev¹,

Gusinsky²,

Шломин³

et al. 2020

Kardiol. serdechno-sosud. khir.

View full text Add to dashboard Cite

Long-Term Results of Combined Aortoiliac and Infrainguinal Arterial Reconstruction for the Treatment of Critical Limb Ischemia

Cited by 5 publications

References 26 publications

Surgical and endovascular hybrid approach in peripheral arterial disease of the lower limbs

Surgical and endovascular hybrid approach in peripheral arterial disease of the lower limbs

Long-Term Outcomes following Common Femoral Endarterectomy

Comparative evaluation of long-term outcomes of various open surgeries on the aortofemoral segment in patients with critical lower limb ischemia

Contact Info

Product

Resources

About